We found that CD68 expression was not associated with the prognosis, higher expression of CD163 (P = 0.04), CD206 (P = 0.342) and CD204 (P = 0.071) was significantly associated with worse prognosis in BLCA. This evidence concerns the gene MRC1 and bladder transitional cell carcinoma.